Literature DB >> 12961037

PET/CT: a new imaging technology in nuclear medicine.

Heiko Schöder1, Yusuf E Erdi, Steven M Larson, Henry W D Yeung.   

Abstract

This review discusses the technical background of combined PET and CT and considers the clinical applications of PET/CT imaging. Questions addressed include: Is PET/CT superior to PET imaging alone? If so, in which patient populations and in what respect? Can PET/CT imaging affect patient management? Can PET/CT be practiced economically? While much work remains to be done, the available data clearly suggest that PET/CT decreases imaging time per patient and, even for the experienced reader, significantly reduces the number of equivocal PET interpretations. PET/CT also has the ability to improve accuracy of PET image interpretation and to affect clinical decision making, thereby improving patient management. The nuclear medicine community should approach this new technology with an open mind and focus on its clinical usefulness. The decision regarding whether PET/CT should be part of the equipment in a given nuclear medicine or radiology practice largely depends on the specific patient population. It is concluded that present skepticism concerning combined PET/CT will subside once critics of this new modality have had the opportunity to clearly see on images its many advantages compared with either PET alone or conventional image fusion approaches.

Entities:  

Mesh:

Year:  2003        PMID: 12961037     DOI: 10.1007/s00259-003-1299-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  48 in total

Review 1.  Oncological applications of FDG PET imaging.

Authors:  D Delbeke
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

2.  Cost considerations regarding an integrated CT-PET system.

Authors:  G K von Schulthess
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.

Authors:  Medhat M Osman; Christian Cohade; Yuji Nakamoto; Laura T Marshall; Jeff P Leal; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

4.  Combined PET/CT Imaging in Oncology. Impact on Patient Management.

Authors:  P G. Kluetz; C C. Meltzer; V L. Villemagne; P E. Kinahan; S Chander; M A. Martinelli; D W. Townsend
Journal:  Clin Positron Imaging       Date:  2000-11

5.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

6.  Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies.

Authors:  J R Votaw; M White
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

7.  Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.

Authors:  Michael P Mac Manus; Kevin Wong; Rodney J Hicks; Jane P Matthews; Andrew Wirth; David L Ball
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

8.  Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.

Authors:  Anthony Hannah; Andrew M Scott; Henri Tochon-Danguy; J Gordon Chan; Tim Akhurst; Salvatore Berlangieri; David Price; Gerard J Smith; Tony Schelleman; W J McKay; Andrew Sizeland
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients.

Authors:  C Burger; G Goerres; S Schoenes; A Buck; A H R Lonn; G K Von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-19       Impact factor: 9.236

View more
  22 in total

1.  Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Authors:  Patrick Reinartz; Franz-Josef Wieres; Wolfram Schneider; Alexander Schur; Ulrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

Review 2.  Scatter modelling and compensation in emission tomography.

Authors:  Habib Zaidi; Kenneth F Koral
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-31       Impact factor: 9.236

3.  Scatter characterization and correction for simultaneous multiple small-animal PET imaging.

Authors:  Rameshwar Prasad; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 4.  Primer on molecular imaging technology.

Authors:  Craig S Levin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

Review 5.  Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.

Authors:  Craig K Abbey; Alexander D Borowsky; Jeffery P Gregg; Robert D Cardiff; Simon R Cherry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

6.  The timing of adoption of positron emission tomography: a real options approach.

Authors:  Paolo Pertile; Emanuele Torri; Luciano Flor; Stefano Tardivo
Journal:  Health Care Manag Sci       Date:  2009-09

7.  Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer.

Authors:  Anna C Pfannenberg; Philip Aschoff; Klaus Brechtel; Mark Müller; Roland Bares; Frank Paulsen; Jutta Scheiderbauer; Godehard Friedel; Claus D Claussen; Susanne M Eschmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-01       Impact factor: 9.236

8.  The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma.

Authors:  İsa Burak Güney; Kadir Alper Küçüker; Volkan İzol; Mustafa Kibar
Journal:  Turk J Urol       Date:  2019-11-01

Review 9.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

10.  Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET.

Authors:  Mi-Jung Lee; Mi Jin Yun; Mi-Suk Park; Seung Hwan Cha; Myeong-Jin Kim; Jong Doo Lee; Ki Whang Kim
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.